Generic Drug Name: Etoposide Capsules USP
Brand Name: PV POSIDE
Indications and Usage:
Treatment of acute lymphocytic leukemia (ALL), refractory acute myeloid leukemia (AML), recurrent or metastatic breast cancer, central nervous system tumors, Ewing’s sarcoma, gestational trophoblastic disease, Hodgkin lymphoma, merkel cell cancer, refractory multiple myeloma, neuroblastoma, neuroendocrine tumors (adrenal gland and carcinoid tumors), non-Hodgkin lymphomas, non-small cell lung cancer (NSCLC), osteosarcoma, ovarian cancer (refractory), prostate cancer, retinoblastoma, metastatic soft tissue sarcoma, thymic malignancies (locally advanced or metastatic), unknown-primary adenocarcinoma, Wilms’ tumor; conditioning regimen for hematopoietic cell transplantation
Certification: WHO-GMP & WHO-GDP
Product Type: Finished Product
Following information is meant for: Wholesalers, Suppliers, Importers, Doctors, CROs, Hospitals, MOH Tender Supplies, NGOs and Institutional Buyers.
Description: Each Capsule contains Etoposide
Strength: 50mg & 100mg
Pack Size: 8 Capsules per pack
Pack Insert: Yes
Storage & Handling:
Store below 25°C
PV Pharma Healthcare Pvt. Ltd. is WHO GMP/WHO GDP Certified Pharmaceutical Manufacturer & Exporter of Etoposide Capsules known as PV POSIDE available in strength of 50mg & 100mg. This product is supplied for Tenders, Emergency imports, Un – licensed Medicines & Orphan drug.